A. Harstrick

10.8k citations
135 papers · 8.5k · 1 hit paper · h-index 36

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

A. Harstrick

129 papers receiving 8.2k citations

A. Harstrick's Hit Papers

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer 2004 · 4.0k citations
4.0k0+7+14Years since publication10002.0k3.0k4.0k

Peers

A. Harstrick
Comparison fields: 5 of 119
  • Oncology 4.8k
  • Hepatology 629
  • Otorhinolaryngology 333
  • Pulmonary and Respiratory Medicine 2.2k
  • Pathology and Forensic Medicine 756
Replace Otilia Dalesio with:
Otilia Dalesio Netherlands
Joseph P. Eder United States
Lee S. Rosen United States
P. Koralewski Poland
Federica Perrone Italy
Per Pfeiffer Denmark
Helen X. Chen United States
Tudor–Eliade Ciuleanu Romania
Howard Safran United States
Harry Bleiberg Belgium
A. Harstrick relative to Otilia Dalesio Netherlands Otilia Dalesio's profile →
Citations per field
00.5×1.6×
Otilia Dalesio · 1×
Citations per year

Countries citing papers authored by A. Harstrick

Since Specialization
Citations

This map shows the geographic impact of A. Harstrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Harstrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Harstrick more than expected).

Fields of papers citing papers by A. Harstrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Harstrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Harstrick. The network helps show where A. Harstrick may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Harstrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Harstrick Line = papers co-authored together A. Harstrick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Hit paper breakdown →
20044041
2 2005393
3 2001279
4 1998249
5 2003232
6 1997171
7 1998151
8 2006138
9 1996123
10 1999115
11 1996109
12 1999107
13
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
1998105
14 199394
15
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
200092
16 199183
17
Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.
199281
18 199680
19 199679
20 200575

About A. Harstrick

A. Harstrick is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 135 papers that have together received 8.5k indexed citations. Recurring topics across this work include Testicular diseases and treatments (30 papers), Colorectal Cancer Treatments and Studies (30 papers), Cancer Treatment and Pharmacology (23 papers), Cancer therapeutics and mechanisms (20 papers), Gastric Cancer Management and Outcomes (16 papers), Lung Cancer Treatments and Mutations (14 papers), Chemotherapy-induced organ toxicity mitigation (13 papers) and Multiple Myeloma Research and Treatments (9 papers). The work is most often cited by research in Oncology (4.8k citations), Hepatology (629 citations), Otorhinolaryngology (333 citations), Pulmonary and Respiratory Medicine (2.2k citations) and Pathology and Forensic Medicine (756 citations). A. Harstrick has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Yves Humblet, Ian Chau, David Cunningham, Armando Santoro, Salvatore Siena, Chris Verslype, Harry Bleiberg, David Khayat, Eric Van Cutsem and M. Mueser. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Anti-Cancer Drugs and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact